Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 23Breast Neoplasms 22Prostatic Neoplasms 21Glioblastoma 19Lung Neoplasms 17Squamous Cell Carcinoma of Head and Neck 16Rectal Neoplasms 12Glioma 12Neoplasms 11Oropharyngeal Neoplasms 10Head and Neck Neoplasms 10Esophageal Neoplasms 8Astrocytoma 8Sarcoma 7Neoplasm Metastasis 7Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 6Esophageal Squamous Cell Carcinoma 6Colorectal Neoplasms 6Carcinoma, Squamous Cell 6Brain Neoplasms 6Triple Negative Breast Neoplasms 5Small Cell Lung Carcinoma 5Pancreatic Neoplasms 5Lymphoma, Follicular 5Hodgkin Disease 5Gliosarcoma 5Carcinoma, Hepatocellular 5Carcinoma 5Burkitt Lymphoma 5

Interventions

Radiotherapy 1Radiation 1Platinum 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified × Radiotherapy × 90 days × Clear all
NCT04580771 2026-04-15

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
22 enrolled
Gynecologic

Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified

Data powered by HemOnc (CC BY 4.0) Colophon âš¡